CN105647922A - 基于一种新gRNA序列的CRISPR-Cas9系统在制备乙肝治疗药物中的应用 - Google Patents
基于一种新gRNA序列的CRISPR-Cas9系统在制备乙肝治疗药物中的应用 Download PDFInfo
- Publication number
- CN105647922A CN105647922A CN201610016280.4A CN201610016280A CN105647922A CN 105647922 A CN105647922 A CN 105647922A CN 201610016280 A CN201610016280 A CN 201610016280A CN 105647922 A CN105647922 A CN 105647922A
- Authority
- CN
- China
- Prior art keywords
- hbv
- cell
- sequence
- grna
- crispr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/10—Vectors comprising a non-peptidic targeting moiety
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2999/00—Further aspects of viruses or vectors not covered by groups C12N2710/00 - C12N2796/00 or C12N2800/00
- C12N2999/007—Technological advancements, e.g. new system for producing known virus, cre-lox system for production of transgenic animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
序号 | 序列 | 得分 | 错配 | UCSC基因 | 位点 |
1 | GCCCTCTCTGGATGTGTCTGAGG | 1.6 | 3MMs[3:4:7] | chr11:+75047287 | |
2 | GCTGTTGCTAGATGTGTCTGAAG | 1.4 | 3MMs[4:6:10] | chr8:+47864962 | |
3 | TGTTTCGTTGGATGTGTCTGAGG | 1.4 | 4MMs[1:2:4:8] | chr17:-74488431 | |
4 | AATTTCGTTGGATGTGTCTGTGG | 1.4 | 4MMs[1:2:4:8] | chr10:-36941610 | |
5 | CCTAGCGCTGGATGTGACTGTGG | 1.3 | 3MMs[1:5:17] | chr22:+49133545 | |
6 | CCTGTCGCTGGAGGTGTCTGTGG | 1.2 | 3MMs[1:4:13] | NR_024527 | chr11:-118015895 |
7 | TCTAGCATTGGATGTGTCTGTGG | 0.9 | 4MMs[1:5:7:8] | chr7:-20747255 | |
8 | ACTTTCCCTTGATGTGTCTGAAG | 0.9 | 4MMs[1:4:7:10] | chr5:-125646588 | |
9 | CTAATGGCTGGATGTGTCTGGGG | 0.8 | 4MMs[1:2:3:6] | chr5:+178213889 | |
10 | TCCGTGGCTGGATGTGTCTGAGG | 0.8 | 4MMs[1:3:4:6] | chr18:-10706739 | |
11 | GCAGGTGCTGGATGTGTCTGGGG | 0.8 | 4MMs[3:4:5:6] | NM_020676 | chr3:+58279310 |
12 | GCATTTGCTTGATGTGTCTGGGG | 0.8 | 4MMs[3:4:6:10] | chr1:+194264939 | |
13 | GGTGTCGCTCGCTGTGTCTGTAG | 0.7 | 4MMs[2:4:10:12] | chr2:+69959464 | |
14 | GCGGACGCTGGATGTGGCTGCAG | 0.6 | 4MMs[3:4:5:17] | chr2:+129349323 | |
15 | CCTCTCCCCGGATGTGTCTGGGG | 0.6 | 4MMs[1:4:7:9] | chr8:+99952106 | |
16 | CCTAAAACTGGATGTGTCTGTGG | 0.6 | 4MMs[1:5:6:7] | chr7:-57842027 | |
17 | GAAATAACTGGATGTGTCTGCAG | 0.5 | 4MMs[2:3:6:7] | chr3:+2365959 | |
18 | GATAACCCTGCATGTGTCTGAGG | 0.5 | 4MMs[2:5:7:11] | chr8:-115773972 | |
19 | GCTGCACCTGGATGTGTCTGGGG | 0.5 | 4MMs[4:5:6:7] | chr10:+50257134 | |
20 | CCTGTTGCAGGATGTGTCTGCAG | 0.5 | 4MMs[1:4:6:9] | chr14:+99788041 |
引物名称 | 核苷酸序列(5’-3’) | 位置(nt) |
RCA1 | AATCCTCACAATACC | 99–113 |
RCA2 | ACCTATTCTCCTCCC | 1758–1744 |
RCA3 | CCTATGGGAGTGGGC | 510–524 |
RCA4 | CCTTTGTCCAAGGGC | 2689–2675 |
RCA5 | ATGCAACTTTTTCAC | 1686–1700 |
RCA6 | CTAGCAGAGCTTGGT | 29–15 |
RCA7 | TAGAAGAAGAACTCC | 2240–2254 |
RCA8 | GGCCCACATATTGT | 2599–2585 |
引物名称 | 核苷酸序列(5’-3’) | 位置(nt) |
cccup | GGGGCGCACCTCTCTTTA | 1523-1540 |
cccdown | AGGCACAGCTTGGAGGC | 1886-1870 |
cccProbe | FAM-TCACCTCTGCCTAATCATCTC-TAMRA | 1825-1845 |
β-up | ACGGCCAGGTCATCACCAT | 661-678 |
β-down | AGGCAGCTCGTAGCTCTT | 802-785 |
βprobe | FAM-CGGGAAATCGTGCGTGAC-TAMRA | 689-706 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610016280.4A CN105647922A (zh) | 2016-01-11 | 2016-01-11 | 基于一种新gRNA序列的CRISPR-Cas9系统在制备乙肝治疗药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610016280.4A CN105647922A (zh) | 2016-01-11 | 2016-01-11 | 基于一种新gRNA序列的CRISPR-Cas9系统在制备乙肝治疗药物中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105647922A true CN105647922A (zh) | 2016-06-08 |
Family
ID=56484128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610016280.4A Pending CN105647922A (zh) | 2016-01-11 | 2016-01-11 | 基于一种新gRNA序列的CRISPR-Cas9系统在制备乙肝治疗药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105647922A (zh) |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105561342A (zh) * | 2016-01-27 | 2016-05-11 | 苏州佰通生物科技有限公司 | 一种治疗乙肝的基因药物及其制备方法 |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
CN106701763A (zh) * | 2016-12-30 | 2017-05-24 | 重庆高圣生物医药有限责任公司 | CRISPR/Cas9靶向敲除人乙肝病毒P基因及其特异性gRNA |
CN107129999A (zh) * | 2017-05-09 | 2017-09-05 | 福建省农业科学院畜牧兽医研究所 | 利用稳转CRISPR/Cas9系统对病毒基因组进行靶向编辑的方法 |
CN107354173A (zh) * | 2016-12-26 | 2017-11-17 | 浙江省医学科学院 | 基于crispr技术和水动力尾静脉注射建立肝脏特异性敲除小鼠模型的方法 |
US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
CN107794272A (zh) * | 2016-09-06 | 2018-03-13 | 中国科学院上海生命科学研究院 | 一种高特异性的crispr基因组编辑体系 |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
CN110322927A (zh) * | 2019-08-02 | 2019-10-11 | 中南大学 | 一种crispr诱导rna文库设计方法 |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
WO2019237391A1 (zh) * | 2018-06-16 | 2019-12-19 | 深圳市博奥康生物科技有限公司 | CRISPR/Cas9 靶向敲除人 TXGP1 基因及其特异性 gRNA |
CN110596384A (zh) * | 2019-10-12 | 2019-12-20 | 南京黎明生物制品有限公司 | 基于Cas蛋白及gRNA复合物制备的人乳头瘤病毒6型和11型免疫检测试剂盒 |
WO2020000464A1 (zh) * | 2018-06-29 | 2020-01-02 | 深圳市博奥康生物科技有限公司 | 一种制备gl-r基因敲除小鼠的方法 |
WO2020000436A1 (zh) * | 2018-06-29 | 2020-01-02 | 深圳市博奥康生物科技有限公司 | 一种特异靶向人INDO基因的gRNA导向序列及其应用 |
US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
CN111139240A (zh) * | 2020-01-20 | 2020-05-12 | 武汉大学 | 一种靶向乙型肝炎病毒的改造的CRISPR/SaCas9系统及其应用 |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
WO2020214003A1 (ko) * | 2019-04-18 | 2020-10-22 | 주식회사 툴젠 | B형 간염 바이러스의 증식을 억제하는 조성물 및 이의 방법 |
US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
CN113249384A (zh) * | 2021-04-27 | 2021-08-13 | 重庆医科大学 | 可靶向编辑HBV cccDNA的特异sgRNA序列及其应用 |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
CN114561392A (zh) * | 2022-03-22 | 2022-05-31 | 绍兴市妇幼保健院 | 一种基于碱基编辑技术关闭靶基因清除HBV e抗原的方法 |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
CN117965634A (zh) * | 2024-04-01 | 2024-05-03 | 北京唯源立康生物科技股份有限公司 | 一种新型hsv-1病毒载体及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1687454A (zh) * | 2005-03-23 | 2005-10-26 | 上海市血液中心 | 基于环介导的等温扩增技术的血液病毒核酸筛查方法 |
CN103911376A (zh) * | 2014-04-03 | 2014-07-09 | 南京大学 | CRISPR-Cas9靶向敲除乙肝病毒cccDNA及其特异性sgRNA |
CN104498493A (zh) * | 2014-12-30 | 2015-04-08 | 武汉大学 | CRISPR/Cas9特异性敲除乙型肝炎病毒的方法以及用于特异性靶向HBV DNA的gRNA |
-
2016
- 2016-01-11 CN CN201610016280.4A patent/CN105647922A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1687454A (zh) * | 2005-03-23 | 2005-10-26 | 上海市血液中心 | 基于环介导的等温扩增技术的血液病毒核酸筛查方法 |
CN103911376A (zh) * | 2014-04-03 | 2014-07-09 | 南京大学 | CRISPR-Cas9靶向敲除乙肝病毒cccDNA及其特异性sgRNA |
CN104498493A (zh) * | 2014-12-30 | 2015-04-08 | 武汉大学 | CRISPR/Cas9特异性敲除乙型肝炎病毒的方法以及用于特异性靶向HBV DNA的gRNA |
Non-Patent Citations (2)
Title |
---|
XING LIU ET AL.: "Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome", 《JOURNAL OF GENERAL VIROLOGY》 * |
刘峰 等: "阿德福韦酯治疗慢性乙型肝炎过程中发生病毒突破患者的(HBV)P基因变异分析", 《山东大学学报(医学版)》 * |
Cited By (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US12006520B2 (en) | 2011-07-22 | 2024-06-11 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
US11920181B2 (en) | 2013-08-09 | 2024-03-05 | President And Fellows Of Harvard College | Nuclease profiling system |
US10954548B2 (en) | 2013-08-09 | 2021-03-23 | President And Fellows Of Harvard College | Nuclease profiling system |
US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
US11299755B2 (en) | 2013-09-06 | 2022-04-12 | President And Fellows Of Harvard College | Switchable CAS9 nucleases and uses thereof |
US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US10912833B2 (en) | 2013-09-06 | 2021-02-09 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
US10682410B2 (en) | 2013-09-06 | 2020-06-16 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
US11124782B2 (en) | 2013-12-12 | 2021-09-21 | President And Fellows Of Harvard College | Cas variants for gene editing |
US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
US10704062B2 (en) | 2014-07-30 | 2020-07-07 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US11578343B2 (en) | 2014-07-30 | 2023-02-14 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US11214780B2 (en) | 2015-10-23 | 2022-01-04 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
CN105561342A (zh) * | 2016-01-27 | 2016-05-11 | 苏州佰通生物科技有限公司 | 一种治疗乙肝的基因药物及其制备方法 |
US11999947B2 (en) | 2016-08-03 | 2024-06-04 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11702651B2 (en) | 2016-08-03 | 2023-07-18 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10947530B2 (en) | 2016-08-03 | 2021-03-16 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
CN107794272A (zh) * | 2016-09-06 | 2018-03-13 | 中国科学院上海生命科学研究院 | 一种高特异性的crispr基因组编辑体系 |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
US11820969B2 (en) | 2016-12-23 | 2023-11-21 | President And Fellows Of Harvard College | Editing of CCR2 receptor gene to protect against HIV infection |
CN107354173A (zh) * | 2016-12-26 | 2017-11-17 | 浙江省医学科学院 | 基于crispr技术和水动力尾静脉注射建立肝脏特异性敲除小鼠模型的方法 |
CN106701763B (zh) * | 2016-12-30 | 2019-07-19 | 重庆高圣生物医药有限责任公司 | CRISPR/Cas9靶向敲除人乙肝病毒P基因及其特异性gRNA |
CN106701763A (zh) * | 2016-12-30 | 2017-05-24 | 重庆高圣生物医药有限责任公司 | CRISPR/Cas9靶向敲除人乙肝病毒P基因及其特异性gRNA |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
CN107129999A (zh) * | 2017-05-09 | 2017-09-05 | 福建省农业科学院畜牧兽医研究所 | 利用稳转CRISPR/Cas9系统对病毒基因组进行靶向编辑的方法 |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11932884B2 (en) | 2017-08-30 | 2024-03-19 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
WO2019237391A1 (zh) * | 2018-06-16 | 2019-12-19 | 深圳市博奥康生物科技有限公司 | CRISPR/Cas9 靶向敲除人 TXGP1 基因及其特异性 gRNA |
WO2020000436A1 (zh) * | 2018-06-29 | 2020-01-02 | 深圳市博奥康生物科技有限公司 | 一种特异靶向人INDO基因的gRNA导向序列及其应用 |
WO2020000464A1 (zh) * | 2018-06-29 | 2020-01-02 | 深圳市博奥康生物科技有限公司 | 一种制备gl-r基因敲除小鼠的方法 |
US11795452B2 (en) | 2019-03-19 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11643652B2 (en) | 2019-03-19 | 2023-05-09 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
WO2020214003A1 (ko) * | 2019-04-18 | 2020-10-22 | 주식회사 툴젠 | B형 간염 바이러스의 증식을 억제하는 조성물 및 이의 방법 |
CN110322927A (zh) * | 2019-08-02 | 2019-10-11 | 中南大学 | 一种crispr诱导rna文库设计方法 |
CN110596384B (zh) * | 2019-10-12 | 2022-08-12 | 南京黎明生物制品有限公司 | 基于Cas蛋白及gRNA复合物制备的人乳头瘤病毒6型和11型免疫检测试剂盒 |
CN110596384A (zh) * | 2019-10-12 | 2019-12-20 | 南京黎明生物制品有限公司 | 基于Cas蛋白及gRNA复合物制备的人乳头瘤病毒6型和11型免疫检测试剂盒 |
CN111139240B (zh) * | 2020-01-20 | 2022-03-15 | 武汉大学 | 一种靶向乙型肝炎病毒的改造的CRISPR/SaCas9系统及其应用 |
CN111139240A (zh) * | 2020-01-20 | 2020-05-12 | 武汉大学 | 一种靶向乙型肝炎病毒的改造的CRISPR/SaCas9系统及其应用 |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
CN113249384A (zh) * | 2021-04-27 | 2021-08-13 | 重庆医科大学 | 可靶向编辑HBV cccDNA的特异sgRNA序列及其应用 |
CN114561392A (zh) * | 2022-03-22 | 2022-05-31 | 绍兴市妇幼保健院 | 一种基于碱基编辑技术关闭靶基因清除HBV e抗原的方法 |
CN117965634A (zh) * | 2024-04-01 | 2024-05-03 | 北京唯源立康生物科技股份有限公司 | 一种新型hsv-1病毒载体及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105647922A (zh) | 基于一种新gRNA序列的CRISPR-Cas9系统在制备乙肝治疗药物中的应用 | |
Zhen et al. | Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus | |
Liu et al. | Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome | |
CN107208102A (zh) | 重组hbv cccdna、其产生方法及其用途 | |
EP2966170A1 (en) | HBV inactivation | |
CN107446923A (zh) | rAAV8‑CRISPR‑SaCas9系统及在制备乙肝治疗药物中的应用 | |
CN106232823A (zh) | 灭活病毒复制的组合物及其制备和使用方法 | |
CN110592172B (zh) | 利用CRISPR/Cas9敲除文库技术筛选JEV抗性基因的方法与靶点 | |
CN108424930A (zh) | 一种HBeAg转基因小鼠模型的构建方法和用途 | |
CN103160619A (zh) | 一种腺病毒多重荧光定量pcr检测试剂盒及其使用方法 | |
CN105907891A (zh) | 检测乙型肝炎患者血液中HBV PgRNA 的方法、试剂盒及其应用 | |
CN103329852A (zh) | 一种hbv持续性感染及纤维化小鼠模型建立 | |
Kayesh et al. | Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA | |
CN103088061A (zh) | 一种rna及载体在制备预防和/或治疗肝癌产品中的应用 | |
CN103436555B (zh) | 携带miR-122的脂肪来源的间充质干细胞在制备肝纤维化治疗制剂的应用 | |
Yi et al. | Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models | |
CN104031999A (zh) | miR-218-5p化合物作为慢性疼痛标志物和在治疗炎症性慢性疼痛药物中的应用 | |
CN103724410A (zh) | 一类调控ccr5和cxcr4基因的融合蛋白及方法 | |
CN109897825A (zh) | 一种简单高效产生乙型肝炎病毒重组cccDNA的细胞系统 | |
CN103374572B (zh) | 一种肝癌细胞的核酸适配体的序列及应用 | |
Kumar et al. | Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes | |
CN102649814A (zh) | 具有HBeAg降解酶活性的蚯蚓蛋白及其应用 | |
CN101906417B (zh) | 针对乙肝病毒的shRNA及携带其的重组腺相关病毒基因治疗载体 | |
CN101653602A (zh) | 乙型肝炎的治疗、预防和诊断试剂 | |
CN104212821B (zh) | Bcr‑abl融合蛋白突变体及其编码基因、表达载体及其构建方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Song Hongbin Inventor after: Jia Leili Inventor after: Hao Rongzhang Inventor after: Su Wenli Inventor after: Li Hao Inventor after: Qiu Shaofu Inventor after: Liu Hongbo Inventor after: Sheng Chunyu Inventor after: Li Peng Inventor after: Qi Lihua Inventor after: Wang Ligui Inventor after: Xie Jing Inventor before: Song Hongbin Inventor before: Jia Leili Inventor before: Hao Rongzhang Inventor before: Su Wenli Inventor before: Qiu Shaofu Inventor before: Li Hao Inventor before: Liu Hongbo Inventor before: Sheng Chunyu Inventor before: Li Peng Inventor before: Qi Lihua Inventor before: Wang Ligui Inventor before: Xie Jing |